A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 19 May 2017
At a glance
- Drugs Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 10 Apr 2017 Status changed from not yet recruiting to completed.
- 05 May 2010 Planned initiation date changed from 1 Sep 2009 to 1 Sep 2010 as reported by ClinicalTrials.gov record.